GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » EV-to-Revenue

Eone Diagnomics Genome Center Co (XKRX:245620) EV-to-Revenue : 1.60 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eone Diagnomics Genome Center Co's enterprise value is ₩118,677 Mil. Eone Diagnomics Genome Center Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩73,966 Mil. Therefore, Eone Diagnomics Genome Center Co's EV-to-Revenue for today is 1.60.

The historical rank and industry rank for Eone Diagnomics Genome Center Co's EV-to-Revenue or its related term are showing as below:

XKRX:245620' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.67   Med: 3.92   Max: 47.62
Current: 1.6

During the past 9 years, the highest EV-to-Revenue of Eone Diagnomics Genome Center Co was 47.62. The lowest was 0.67. And the median was 3.92.

XKRX:245620's EV-to-Revenue is ranked better than
73.54% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs XKRX:245620: 1.60

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Eone Diagnomics Genome Center Co's stock price is ₩415.00. Eone Diagnomics Genome Center Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩736.78. Therefore, Eone Diagnomics Genome Center Co's PS Ratio for today is 0.56.


Eone Diagnomics Genome Center Co EV-to-Revenue Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co EV-to-Revenue Chart

Eone Diagnomics Genome Center Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 3.70 4.09 3.30 2.50 1.26

Eone Diagnomics Genome Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 2.31 1.70 1.26 0.89

Competitive Comparison of Eone Diagnomics Genome Center Co's EV-to-Revenue

For the Diagnostics & Research subindustry, Eone Diagnomics Genome Center Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eone Diagnomics Genome Center Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eone Diagnomics Genome Center Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eone Diagnomics Genome Center Co's EV-to-Revenue falls into.



Eone Diagnomics Genome Center Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Eone Diagnomics Genome Center Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=118677.160/73965.878
=1.60

Eone Diagnomics Genome Center Co's current Enterprise Value is ₩118,677 Mil.
Eone Diagnomics Genome Center Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩73,966 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eone Diagnomics Genome Center Co  (XKRX:245620) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Eone Diagnomics Genome Center Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=415.00/736.778
=0.56

Eone Diagnomics Genome Center Co's share price for today is ₩415.00.
Eone Diagnomics Genome Center Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩736.78.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eone Diagnomics Genome Center Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines